1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014" provides data on the Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) 18
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials 23
Prominent Drugs 24
Latest Clinical Trials News on Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) 25
Mar 29, 2012: Oncolytics Biotech To Present Preclinical Research Data On Reovirus At AACR Annual Meeting 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Sarcoma Alliance for Research through Collaboration 26
Clinical Trial Overview of Sarcoma Alliance for Research through Collaboration 26
MethylGene Inc. 27
Clinical Trial Overview of MethylGene Inc. 27
Clinical Trial Overview of Top Institutes / Government 28
National Cancer Institute 28
Clinical Trial Overview of National Cancer Institute 28
St. Jude Children's Research Hospital 29
Clinical Trial Overview of St. Jude Children's Research Hospital 29
OHSU Knight Cancer Institute 30
Clinical Trial Overview of OHSU Knight Cancer Institute 30
Japan Medical Association 31
Clinical Trial Overview of Japan Medical Association 31
Children's Oncology Group 32
Clinical Trial Overview of Children's Oncology Group 32
University of Washington 33
Clinical Trial Overview of University of Washington 33
Five Key Clinical Profiles 34
Appendix 149
Abbreviations 149
Definitions 149
Research Methodology 150
Secondary Research 150
About GlobalData 151
Contact Us 151
Disclaimer 151
Source 152

List of Tables
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Region, 2014* 6
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Suspended Clinical Trials, 2014* 18
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Terminated Clinical Trials, 2014* 19
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarcoma Alliance for Research through Collaboration, 2014* 26
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by MethylGene Inc., 2014* 27
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 28
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, 2014* 29
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by OHSU Knight Cancer Institute, 2014* 30
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Medical Association, 2014* 31
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 32
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 33

List of Figures
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 150

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.